4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-17-001161
$NBYCIK 0001389545operating
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:35 PM ET
Size
5.5 KB
Accession
0001437749-17-001161
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
stock option (right to buy)
2017-01-25+238,609→ 936,857 totalExercise: $3.60From: 2017-01-31Exp: 2027-01-25→ Common Stock (238,609 underlying)
Footnotes (2)
- [F1]Granted pursuant to the 2007 Omnibus Incentive Plan
- [F2]Granted pursuant to the employment agreement signed between Company and Executive on May 26, 2016: Executive shall be entitled to a stock option grant equal to six percent (6%) of the aggregate number of shares issued pursuant to the Company's warrant exercises in the 2016 calendar year. Such grant shall be approved and granted by the Board at the first Board meeting in January 2017. The grant shall completely vest on January 31, 2017 in direct proportion to the percentage achievement of the stated 2016 corporate goals, as approved and determined by the Board of Directors.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 6:35 PM ET
- Size
- 5.5 KB